CSIMarket Company Name, Ticker, Industry, else..
 
Aurinia Pharmaceuticals Inc   (NASDAQ: AUPH)
 

AUPH's Market share relative to its competitors, as of Q3 2025

As of Q3 2025 (Revenue in Millions of $)

Date modified: 2025-11-28T19:21:56+00:00




Download as CSV

COMPANY NAME REVENUES
12 Months Ending
Q3 2025		 MARKET SHARE
12 Months
Q3 2025		 MARKET SHARE
MRQ
Q3 2025		 MARKET SHARE
A Quarter Before
Q2 2025
Aurinia Pharmaceuticals Inc 265.81 0.05% 0.06 % 0.06 %
Johnson and Johnson 92,149.00 18.80% 18.48% 18.91%
Merck and Co Inc 64,235.00 13.10% 13.30% 12.59%
Eli Lilly And Company 59,419.80 12.12% 13.55% 12.39%
Sanofi 49,599.72 10.12% 10.12% 0.00%
Novartis Ag 46,660.00 9.52% 9.52% 0.00%
Astrazeneca Plc 45,811.00 9.34% 9.34% 0.00%
Amgen Inc 33,424.00 6.82% 7.36% 7.31%
Takeda Pharmaceutical Company Limited 29,166.69 5.95% 5.95% 0.00%
Gilead Sciences Inc 29,087.00 5.93% 5.98% 5.64%
Teva Pharmaceutical Industries Limited 16,778.00 3.42% 3.45% 3.33%
Viatris Inc 14,124.40 2.88% 2.90% 2.85%
Organon and Co 6,289.00 1.28% 1.23% 1.20%
Corcept Therapeutics Inc 741.17 0.15% 0.16% 0.15%
Madrigal Pharmaceuticals Inc 740.64 0.15% 0.22% 0.17%
Amicus Therapeutics inc 597.49 0.12% 0.13% 0.12%
Myovant Sciences Ltd 379.11 0.08% 0.08% 0.08%
Mannkind Corporation 313.79 0.06% 0.06% 0.06%
Puma Biotechnology Inc 212.00 0.04% 0.04% 0.04%
Calliditas Therapeutics Ab 129.24 0.03% 0.03% 0.00%
X4 Pharmaceuticals Inc 33.98 0.01% 0.00% 0.00%
Casi Pharmaceuticals inc 28.54 0.01% 0.01% 0.00%
Allarity Therapeutics Inc 23.79 0.00% 0.00% 0.00%
Iterum Therapeutics Plc 14.32 0.00% 0.00% 0.00%
Chinook Therapeutics Inc 5.85 0.00% 0.00% 0.00%
Arbutus Biopharma Corp 5.21 0.00% 0.00% 0.00%
I mab 3.89 0.00% 0.00% 0.00%
Therapeuticsmd Inc 2.36 0.00% 0.00% 0.00%
Immuron Limited 1.48 0.00% 0.00% 0.00%
Akari Therapeutics Plc 0.00 0.00% 0.00% 0.00%
Biophytis Sa 0.00 0.00% 0.00% 0.00%
Medicinova Inc 0.00 0.00% 0.00% 0.00%
SUBTOTAL 490,242.27 100% 129,864.60 100%



AUPH's Market share relative to its competitors, as of Q3 2025 within the Major Pharmaceutical Preparations Industry
As of Q3 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2025		 MARKET SHARE
12 Months Ending
Q2 2025		 MARKET SHARE
MRQ
Q3 2025		 MARKET SHARE

Q2 2025
Aurinia Pharmaceuticals Inc 0.06% 0.06% 0.07 % 0.06 %
Johnson and Johnson 21.55% 21.39% 21.32% 21.72%
Merck and Co Inc 15.02% 15.01% 15.35% 14.46%
Eli Lilly And Company 13.89% 12.57% 15.64% 14.23%
Sanofi 11.60% 12.28% 11.60% 12.28%
Novartis Ag 10.91% 12.23% 10.91% 12.23%
Astrazeneca Plc 10.71% 10.47% 10.71% 10.47%
Takeda Pharmaceutical Company Limited 6.82% 6.58% 6.82% 6.58%
Teva Pharmaceutical Industries Limited 3.92% 3.92% 3.98% 3.82%
Viatris Inc 3.30% 3.33% 3.34% 3.28%
Organon and Co 1.47% 1.49% 1.42% 1.38%
Corcept Therapeutics Inc 0.17% 0.17% 0.18% 0.18%
Madrigal Pharmaceuticals Inc 0.17% 0.12% 0.26% 0.19%
Amicus Therapeutics inc 0.14% 0.13% 0.15% 0.14%
Myovant Sciences Ltd 0.09% 0.08% 0.09% 0.10%
Mannkind Corporation 0.07% 0.07% 0.07% 0.07%
Puma Biotechnology Inc 0.05% 0.06% 0.05% 0.05%
Calliditas Therapeutics Ab 0.03% 0.02% 0.03% 0.02%
Casi Pharmaceuticals inc 0.01% 0.01% 0.01% 0.01%
Allarity Therapeutics Inc 0.01% 0.01% 0.00% 0.00%
Iterum Therapeutics Plc 0.00% 0.00% 0.00% 0.00%
Chinook Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Arbutus Biopharma Corp 0.00% 0.00% 0.00% 0.00%
I mab 0.00% 0.00% 0.00% 0.00%
Therapeuticsmd Inc 0.00% 0.00% 0.00% 0.00%
Immuron Limited 0.00% 0.00% 0.00% 0.00%
Akari Therapeutics Plc 0.00% 0.00% 0.00% 0.00%
Biophytis Sa 0.00% 0.00% 0.00% 0.00%
Medicinova Inc 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



AUPH's Market share relative to its competitors, as of Q3 2025 within the Healthcare Sector
As of Q3 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2025		 MARKET SHARE
12 Months Ending
Q2 2025		 MARKET SHARE
MRQ
Q3 2025		 MARKET SHARE

Q2 2025
Aurinia Pharmaceuticals Inc 0.05% 0.05% 0.06 % 0.06 %
Johnson and Johnson 18.80% 18.68% 18.48% 18.91%
Merck and Co Inc 13.10% 13.11% 13.30% 12.59%
Eli Lilly And Company 12.12% 10.98% 13.55% 12.39%
Sanofi 10.12% 10.72% 10.12% 10.72%
Novartis Ag 9.52% 10.68% 9.52% 10.68%
Astrazeneca Plc 9.34% 9.14% 9.34% 9.14%
Amgen Inc 6.82% 6.71% 7.36% 7.31%
Takeda Pharmaceutical Company Limited 5.95% 5.75% 5.95% 5.75%
Gilead Sciences Inc 5.93% 5.95% 5.98% 5.64%
Teva Pharmaceutical Industries Limited 3.42% 3.43% 3.45% 3.33%
Viatris Inc 2.88% 2.91% 2.90% 2.85%
Organon and Co 1.28% 1.30% 1.23% 1.20%
Corcept Therapeutics Inc 0.15% 0.15% 0.16% 0.15%
Madrigal Pharmaceuticals Inc 0.15% 0.11% 0.22% 0.17%
Amicus Therapeutics inc 0.12% 0.12% 0.13% 0.12%
Myovant Sciences Ltd 0.08% 0.07% 0.08% 0.08%
Mannkind Corporation 0.06% 0.06% 0.06% 0.06%
Puma Biotechnology Inc 0.04% 0.05% 0.04% 0.04%
Calliditas Therapeutics Ab 0.03% 0.02% 0.03% 0.02%
X4 Pharmaceuticals Inc 0.01% 0.01% 0.00% 0.00%
Casi Pharmaceuticals inc 0.01% 0.01% 0.01% 0.01%
Allarity Therapeutics Inc 0.00% 0.01% 0.00% 0.00%
Iterum Therapeutics Plc 0.00% 0.00% 0.00% 0.00%
Chinook Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Arbutus Biopharma Corp 0.00% 0.00% 0.00% 0.00%
I mab 0.00% 0.00% 0.00% 0.00%
Therapeuticsmd Inc 0.00% 0.00% 0.00% 0.00%
Immuron Limited 0.00% 0.00% 0.00% 0.00%
Akari Therapeutics Plc 0.00% 0.00% 0.00% 0.00%
Biophytis Sa 0.00% 0.00% 0.00% 0.00%
Medicinova Inc 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



Note: Market share is calculated based on total revenue. To get a more accurate picture of Aurinia Pharmaceuticals Inc's market divisions, geographic dispersion, segments, products, and services, visit Aurinia Pharmaceuticals Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.